Studies indicate that PTP1B is the primary PTP capable of dephosphorylating c-Src in breast cancer cell lines and thus controlling its kinase activity.42 Our findings suggest that when D492 cells are treated with the PTP1B inhibitor Src activity is diminished, identifying PTP1B as a positive regulator of Src. This evidence concerns the gene SRC and breast cancer.